Public Company Limited and its subsidiaries ("Group") would like to clarify In the case of the operating results of the Group for the second quarter of 2 0 2 0 ended June 30th, 2 0 2 0 , the change was
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 30 September 2017 2018 THB mm % THB mm % THB mm % Sale Revenue Revenue from selling product under Company’s trademark 1
the following details. Financial performance Statement of income Consolidated financial statements for the 9-month ended 30 September 2017 30 September 2018 Change (Reviewed/Restated) (Reviewed
increase 33.4. Details of the change in revenue are as follows: 1. Income from contracts with customers in the second quarter was 87.0 million baht slightly reduced 4.8 million baht or decrease 5.2% and for
Balance by Quarter Change Q3-24 Q2-24 Q3-23 Q3-24 VS Q2-24 Q3-24 VS Q3-23 (Million Baht: MB) (MB) % (MB) % Total revenue 1,926.4 1,866.9 1,704.9 59.5 3.2 221.5 13.0 Total operating expenses 1,738.9 1,698.2
, the details of the Company’s performance are explained as follows: Rental and Services Income Rental and service income for the second quarter in 2018 was equal to 159.1 million baht lower than the
financial costs compared to the same period last year. Thus, the details of the Company’s performance are explained as follows: Rental and Services Income Rental and service income for the third quarter in
Revenue by Product Line for the three months period ended March 31 (YoY) Product Line/ Business Group Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 31 March 2018
result. Dear sir, We, Unimit Engineering Public Company Limited (UEC) , would like to clarify the change in operating result for Q2/2018 which changing over 20% from the same period last year as follows